Search | GSK

Meet The Management Early Pipeline Transcript

https://www.gsk.com/media/11727/meet-the-management-early-pipeline-transcript.pdf

First published: 19 December 2024

Simon Dingemans, Chief Financial Officer, gave a presentation at the Bank of America Merrill Lynch Global Healthcare conference in London.

https://www.gsk.com/en-gb/investors/speeches-and-presentations/bank-of-america-merrill-lynch-global-healthcare-conference-london-uk/

First published: 19 September 2014

https://www.gsk.com/media/8116/transcript-gsk-vaccines-event-26sep19-updated-24-oct.pdf

First published: 01 June 2022

https://www.gsk.com/media/8163/investor-event-full-transcript.pdf

First published: 06 June 2022

GSK announced that, it has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India.

https://www.gsk.com/en-gb/media/press-releases/gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-per-cent-after-open-offer/

First published: 10 March 2014

GSK has today been informed by UK's SFO that it has opened a formal criminal investigation into the Group’s commercial practices.

https://www.gsk.com/en-gb/media/press-releases/serious-fraud-office-investigation/

First published: 27 May 2014

Jon was appointed to the Board as Chair on 1 September 2019 with extensive international financial, life sciences and governance experience.

https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/sir-jonathan-symonds/

First published: 08 November 2024

GSK announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for patients with severe eosinophilic asthma

https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submissions-for-mepolizumab-in-severe-eosinophilic-asthma/

First published: 05 November 2014

GSK announces core EPS of 112.2p and dividend of 78p.

https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-fourth-quarter-2013/

First published: 05 February 2014

GSK is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc).

https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-divestment-of-nimenrix-and-mencevax/

First published: 22 June 2015